Caroline C. Whitacre

Introduction Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system (CNS) affecting nearly 3 million people worldwide that can cause significant disability.1 Although much progress has been made in understanding the pathogenesis of MS and there are many effective treatments for relapsing disease, strategies that prevent incident cases do not yet exist, there is a paucity of therapies that slow disability progression or restore function, and cures for MS...

Skip to main content Intended for healthcare professionals Get full access to this article View all access and purchase options for this article. Data availability statement Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. References 1. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 2020; 26(14): 1816–1821. 2.

Members of Congress return to Washington this week with a daunting task in front of them: reaching agreement on funding the federal budget for the remainder of the fiscal year and averting a government shutdown. Moreover, the negotiations and decisions made this week about how to prioritize federal spending are a likely foreshadowing of what is to come when Congress quickly shifts its focus to next year’s budget.